Dow Down 3.39% Nasdaq Down 4.12%

Clovis Oncology, Inc. (CLVS)

-NasdaqGS
13.01 Down 0.92(6.60%) 4:00PM EDT
|After Hours : 13.01 0.00 (0.00%) 7:20PM EDT
Prev Close:13.93
Open:13.23
Bid:12.69 x 200
Ask:17.00 x 1200
1y Target Est:17.50
Beta:1.26498
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:12.99 - 13.86
52wk Range:11.58 - 116.75
Volume:972,019
Avg Vol (3m):1,429,510
Market Cap:499.40M
P/E (ttm):N/A
EPS (ttm):-10.05
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CLVSDown 6.60%499.40M
IMMUDown 13.20%205.72M
THLDDown 6.93%27.17M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-8.00
Quarterly EPS Est (Jun-16) :-2.13
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback